1
Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion Dependent
Condition(s):Myelodysplastic SyndromesLast Updated:February 7, 2017Unknown status
Decitabine: 542 Clinical Trials, Page 1 of 55
Hide Studies Not Open or Pending
2
Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)
Condition(s):Liver Metastasis; Colorectal CancerLast Updated:October 27, 2017Completed
3
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
Condition(s):Mesothelioma; Malignant Mesothelioma (MM); Early-stage Mesothelioma; Subclinical Mesothelioma; BRCA1-Associated Protein-1 (BAP1) Mutations; Early-stage BAP1-associated MalignanciesLast Updated:November 29, 2023Not yet recruiting
4
To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males
Condition(s):HealthyLast Updated:September 7, 2023Recruiting
5
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
Condition(s):Relapsed Acute Myeloid LeukemiaLast Updated:December 28, 2022Completed
6
Ruxolitinib and Decitabine for High Risk Hematological Malignancies
Condition(s):Peripheral Blood Stem Cell TransplantationLast Updated:October 20, 2020Recruiting
7
Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid LeukemiaLast Updated:September 5, 2023Completed
8
Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML
Condition(s):Myelodysplastic Syndrome; Acute Myeloid LeukemiaLast Updated:November 20, 2015Unknown status
9
Phase I, Dose Escalation Study of Decitabine
Condition(s):Leukemia, Lymphoblastic, Acute; Leukemia, Myeloid Acute; Hematopoetic MyelodysplasiaLast Updated:October 15, 2018Completed
10
Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults
Condition(s):Childhood Solid Tumor; Childhood Lymphoma; Relapsed Cancer; Refractory Cancer; Adult Solid Tumor; Adult LymphomaLast Updated:January 31, 2023Active, not recruiting